LIM mineralization protein-1 suppresses TNF-α induced intervertebral disc degeneration by maintaining nucleus pulposus extracellular matrix production and inhibiting matrix metalloproteinases expression

J Orthop Res. 2015 Mar;33(3):294-303. doi: 10.1002/jor.22732. Epub 2014 Oct 21.

Abstract

Imbalanced metabolism of Nucleus pulposus (NP) extracellular matrix (ECM) is closely correlated to Intervertebral Disc Degenerative Disease. LIM mineralization protein-1 (LMP-1) has been proven to induce sulfated glycosaminoglycan (sGAG) production in NP and have an anti-inflammatory effect in pre-osteoclast. However, whether it has any effect on the NP ECM production and degradation under inflammatory stimulation has not been studied. In the current study, a TNF-α induced cell model was established in vitro. Lentivirus encoding LMP-1 (LV-LMP-1) and short heparin LMP-1 (LV-shLMP-1) were constructed to overexpress and knockdown LMP-1 expression in NP cells. LMP-1 mRNA level was regulated in a dose-dependent manner after transfection. LV-LMP-1 increased whereas LV-shLMP-1 decreased collagen II, aggrecan, versican expression, and sGAG production. LV-LMP-1 abolished while LV-shLMP-1 aggravated TNF-α mediated down-regulation of the above matrix genes via ERK1/2 activation. Moreover, LV-LMP-1 abrogated TNF-α induced MMP-3 and MMP-13 expression via inhibiting p65 translocation and MMP-3 and MMP-13 promoter activity. These results indicated that LMP-1 had an ECM production maintenance effect under inflammatory stimulation. This effect was via up-regulation of matrix genes expression at least partially through ERK1/2 activation, and down-regulation of MMPs expression through NF-κB inhibition.

Keywords: LIM Mineralization Protein-1; NF-κB; extracellular matrix; intervertebral disc degeneration; matrix metalloproteinase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing / physiology*
  • Animals
  • Cells, Cultured
  • Cytoskeletal Proteins / physiology*
  • Extracellular Matrix / metabolism*
  • Extracellular Signal-Regulated MAP Kinases / physiology
  • Glycosaminoglycans / biosynthesis
  • Humans
  • Intervertebral Disc / cytology
  • Intervertebral Disc / metabolism*
  • Intervertebral Disc Degeneration / prevention & control*
  • LIM Domain Proteins / physiology*
  • Matrix Metalloproteinase 13 / genetics
  • Matrix Metalloproteinase 3 / genetics
  • Matrix Metalloproteinase Inhibitors
  • NF-kappa B / physiology
  • Promoter Regions, Genetic
  • Rats
  • Rats, Wistar
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Adaptor Proteins, Signal Transducing
  • Cytoskeletal Proteins
  • Glycosaminoglycans
  • LIM Domain Proteins
  • Matrix Metalloproteinase Inhibitors
  • NF-kappa B
  • PDLIM7 protein, human
  • Tumor Necrosis Factor-alpha
  • Extracellular Signal-Regulated MAP Kinases
  • Matrix Metalloproteinase 13
  • Matrix Metalloproteinase 3